MCB's Molecular Therapeutics (MTx) division announced today the launch of the new Molecular Therapeutics Initiative (MTI) designed to accelerate drug discovery by tackling the "undruggable" & discovering new therapeutics modalities. Read more...
MCB's Molecular Therapeutics (MTx) division announced today the launch of the new Molecular Therapeutics Initiative (MTI) designed to accelerate drug discovery by tackling the "undruggable" & discovering new therapeutics modalities. Read more...